The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Pathogenesis of Mucormycosis
Open accessAbstract
Mucormycosis is a life-threatening infection that occurs in patients who are immunocompromised because of diabetic ketoacidosis, neutropenia, organ transplantation, and/or increased serum levels of available iron. Because of the increasing prevalence of diabetes mellitus, cancer, and organ transplantation, the number of patients at risk for this deadly infection is increasing. Despite aggressive therapy, which includes disfiguring surgical debridement and frequently adjunctive toxic antifungal therapy, the overall mortality rate is high. New strategies to prevent and treat mucormycosis are urgently needed. Understanding the pathogenesis of mucormycosis and the host response to invading hyphae ultimately will provide targets for novel therapeutic interventions. In this supplement, we review the current knowledge about the virulence traits used by the most common etiologic agent of mucormycosis, Rhizopus oryzae. Because patients with elevated serum levels of available iron are uniquely susceptible to mucormycosis and these infections are highly angioinvasive, emphasis is placed on the ability of the organism to acquire iron from the host and on its interactions with endothelial cells lining blood vessels. Several promising therapeutic strategies in preclinical stages are identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Self-citationA higher-level phylogenetic classification of the Fungi
Hibbett, D. S., Binder, M., Bischoff, J. F., Blackwell, M., Cannon, P. F., Eriksson, O. E., Huhndorf, S., James, T., Kirk, P. M., Lücking, R., et al. (2007) · Mycological Research · doi:10.1016/j.mycres.2007.03.004 · Cited by 2,390
Ribes, J. A., Vanover-Sams, C. L., & Baker, D. J. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.236 · Cited by 1,711
Novel perspectives on mucormycosis: pathophysiology, presentation, and management
Spellberg, B., Edwards, J., & Ibrahim, A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.556-569.2005 · Cited by 1,537
Self-citationTigertt, W. D. (1986) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1986.35.3.tm0350030671b · Cited by 1,458
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
GRP78 Induction in Cancer: Therapeutic and Prognostic Implications
Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0325 · Cited by 856
ER chaperones in mammalian development and human diseases
Ni, M., & Lee, A. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.045 · Cited by 735
A permease-oxidase complex involved in high-affinity iron uptake in yeast.
Stearman, R., Yuan, D. S., Yamaguchi-Iwai, Y., Klausner, R. D., & Dancis, A. (1996) · Science · doi:10.1126/science.271.5255.1552 · Cited by 683
Pathogenic fungus harbours endosymbiotic bacteria for toxin production
Partida-Martinez, L. P., & Hertweck, C. (2005) · Nature · doi:10.1038/nature03997 · Cited by 677
Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 674
Self-citationWang, M., Wey, S., Zhang, Y., Ye, R., & Lee, A. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2485 · Cited by 609
Stress Induction of GRP78/BiP and Its Role in Cancer
Li, J., & Lee, A. (2006) · Current Molecular Medicine · doi:10.2174/156652406775574523 · Cited by 599
Marty, F. M., Cosimi, L. A., & Baden, L. R. (2004) · New England Journal of Medicine · doi:10.1056/nejm200402263500923 · Cited by 426
Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole
Imhof, A., Balajee, S. A., Fredricks, D. N., Englund, J. A., & Marr, K. A. (2004) · Clinical Infectious Diseases · doi:10.1086/423274 · Cited by 402
Genomic Analysis of the Basal Lineage Fungus Rhizopus oryzae Reveals a Whole-Genome Duplication
Ma, L.-J., Ibrahim, A. S., Skory, C., Grabherr, M. G., Burger, G., Butler, M., Elias, M., Idnurm, A., Lang, B. F., Sone, T., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000549 · Cited by 379
Self-citationArtis, W. M., Fountain, J. A., Delcher, H. K., & Jones, H. E. (1982) · Diabetes · doi:10.2337/diabetes.31.12.1109 · Cited by 369
Boelaert, J. R., de Locht, M., Van Cutsem, J., Kerrels, V, Cantinieaux, B., Verdonck, A., Van Landuyt, H. W., & Schneider, Y. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116419 · Cited by 340
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
Liu, M., Spellberg, B., Phan, Q. T., Fu, Y., Fu, Y., Lee, A. S., Edwards, J. E., Filler, S. G., & Ibrahim, A. S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42164 · Cited by 324
Self-citationThe iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308
Self-citationSiwek, G. T., Dodgson, K. J., de Margarida, M.-S., Bartelt, L. A., Kilborn, S. B., Hoth, P. L., Diekema, D. J., & Pfaller, M. A. (2004) · Clinical Infectious Diseases · doi:10.1086/422723 · Cited by 293
SreA‐mediated iron regulation in Aspergillus fumigatus
Schrettl, M., Kim, H. S., Eisendle, M., Kragl, C., Nierman, W. C., Heinekamp, T., Werner, E. R., Jacobsen, I., Illmer, P., Yi, H., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06376.x · Cited by 266
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment
Ibrahim, A. S., Spellberg, B., & Edwards, J. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283165fd1 · Cited by 264
Self-citationAcquisition, Transport, and Storage of Iron by Pathogenic Fungi
Howard, D. H. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.3.394 · Cited by 260
Improved Outcome of Zygomycosis in Patients with Hematological Diseases?
Gleissner, B., Schilling, A., Anagnostopolous, I., Siehl, I., & Thiel, E. (2004) · Leukemia & Lymphoma · doi:10.1080/10428190310001653691 · Cited by 227
Gartenberg, G., Bottone, E. J., Keusch, G. T., & Weitzman, I. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811162992007 · Cited by 223
Agents of mucormycosis and related species.
Sugar, A. M., Mandell, G. L., Douglas, R. G., & Bennett, J. E. (1990) · Cited by 220
Waldorf, A. R., Ruderman, N., & Diamond, R. D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111395 · Cited by 215
Maertens, J., Demuynck, H., Verbeken, E., Zachée, P., Verhoef, G., Vandenberghe, P., & Boogaerts, M. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701885 · Cited by 213
Deferoxamine Therapy and Mucormycosis in Dialysis Patients: Report of an International Registry
Boelaert, J. R., Fenves, A. Z., & Coburn, J. W. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80606-8 · Cited by 203
Worsham, P. L., & Goldman, W. E. (1988) · Medical Mycology · doi:10.1080/02681218880000211 · Cited by 178
Chinn, R. Y., & Diamond, R. D. (1982) · Infection and Immunity · doi:10.1128/iai.38.3.1123-1129.1982 · Cited by 176
Boelaert, J. R., Van Cutsem, J., de Locht, M., Schneider, Y.-J., & Crichton, R. R. (1994) · Kidney International · doi:10.1038/ki.1994.89 · Cited by 168
The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis
Ibrahim, A. S., Gebremariam, T., Lin, L., Luo, G., Husseiny, M. I., Skory, C. D., Fu, Y., French, S. W., Edwards, Jr., & Spellberg, B. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07234.x · Cited by 161
Self-citationIron Source Preference and Regulation of Iron Uptake in Cryptococcus neoformans
Jung, W. H., Sham, A., Lian, T., Singh, A., Kosman, D. J., & Kronstad, J. W. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040045 · Cited by 159
Deferiprone iron chelation as a novel therapy for experimental mucormycosis
Ibrahim, A. S., Edwards, J. E., Fu, Y., & Spellberg, B. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl350 · Cited by 156
Self-citationMitchell, S., Gray, J., Morgan, M. E., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05059-3 · Cited by 154
Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis
Chamilos, G., Lewis, R. E., Hu, J., Xiao, L., Żal, T., Gilliet, M. F., Halder, G. A., & Kontoyiannis, D. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709578105 · Cited by 147
Self-citationIron Acquisition from Transferrin by Candida albicans Depends on the Reductive Pathway
Knight, S. A. B., Vilaire, G., Lesuisse, E., & Dancis, A. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5482-5492.2005 · Cited by 145
Rhizopus oryzae Adheres to, Is Phagocytosed by, and Damages Endothelial Cells In Vitro
Ibrahim, A. S., Spellberg, B. J., Avanesian, V., Fu, Y., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.778-783.2005 · Cited by 142
Self-citationHaemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase
Santos, R., Buisson, N., Knight, S., Dancis, A., Camadro, J.-M., & Lesuisse, E. (2003) · Microbiology · doi:10.1099/mic.0.26108-0 · Cited by 139
Taxonomic, R. (1980) · Cited by 137
Pulmonary defense mechanisms against opportunistic fungal pathogens.
Waldorf, A. R. (1989) · PubMed · Cited by 132
Lamaris, G. A., Ben‐Ami, R., Lewis, R. E., Chamilos, G., Samonis, G., & Kontoyiannis, D. P. (2009) · The Journal of Infectious Diseases · doi:10.1086/597615 · Cited by 129
Self-citationRhizoferrin: A complexone type siderophore of the mocorales and entomophthorales (Zygomycetes)
Thieken, A., & Winkelmann, G. ⁄. N. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05285.x · Cited by 126
de Locht, M., Boelaert, J. R., & Schneider, Y. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90314-x · Cited by 124
Ben‐Ami, R., Luna, M. A., Lewis, R. E., Walsh, T. J., & Kontoyiannis, D. P. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.06.002 · Cited by 112
Self-citationBoelaert, J., van Roost, G., Vergauwe, P. L., Verbanck, J. J., Vroey, C. D., & Segaert, M. F. (1988) · PubMed · Cited by 101
Chamilos, G., Lewis, R. E., Lamaris, G. A., Walsh, T. J., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01136-07 · Cited by 100
Self-citationMead, J. H. (1979) · JAMA · doi:10.1001/jama.242.3.272 · Cited by 90
Bouchara, J. P., Oumeziane, N. A., Lissitzky, J., Larcher, G., Tronchin, G., & Chabasse, D. (1996) · PubMed · Cited by 86
Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro
Diamond, R. D., Haudenschild, C. C., & Erickson, N. F. (1982) · Infection and Immunity · doi:10.1128/iai.38.1.292-297.1982 · Cited by 84
Ibrahim, A. S., Gebremariam, T., Liu, M., Chamilos, G., Kontoyiannis, D. P., Mink, R. B., Kwon-Chung, K. J., Fu, Y., Skory, C. D., Edwards, J. E., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/591461 · Cited by 76
Self-citationBreakthrough Zygomycosis during Empirical Voriconazole Therapy in Febrile Patients with Neutropenia
Oren, I. (2005) · Clinical Infectious Diseases · doi:10.1086/427759 · Cited by 75
Mucormycosis among Patients on Dialysis
Boelaert, J. R., Fenves, A. Z., & Coburn, J. W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210313 · Cited by 37
Activity of Deferasirox in Mucorales : Influences of Species and Exogenous Iron
Lewis, R. E., Pongas, G. N., Albert, N. D., Ben‐Ami, R., Walsh, T. J., & Kontoyiannis, D. P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00792-10 · Cited by 26
Self-citationRegistry on Mucormycosis in Dialysis Patients
Boelaert, J. R., Fenves, A. Z., & Coburn, J. W. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.914 · Cited by 17
Cited by
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
John, T. M., Jacob, C. N., & Kontoyiannis, D. P. (2021) · Journal of Fungi · doi:10.3390/jof7040298 · Cited by 524
Self-citationPatel, A., Kaur, H., Xess, I., Michael, J. S., Savio, J., Rudramurthy, S., Singh, R., Shastri, P., Umabala, P., Sardana, R., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.021 · Cited by 405
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Pal, R., Singh, B., Bhadada, S. K., Banerjee, M., Bhogal, R. S., Hage, N., & Kumar, A. (2021) · Mycoses · doi:10.1111/myc.13338 · Cited by 289
Millon, L., Herbrecht, R., Grenouillet, F., Morio, F., Alanio, A., Letscher-Bru, V., Cassaing, S., Chouaki, T., Kauffmann-Lacroix, C., Poirier, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.006 · Cited by 260
CotH3 mediates fungal invasion of host cells during mucormycosis
Gebremariam, T., Liu, M., Luo, G., Bruno, V., Phan, Q. T., Waring, A. J., Edwards, J. E., Filler, S. G., Yeaman, M. R., & Ibrahim, A. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71349 · Cited by 254
Self-citation
Metadata
- Authors
- Ibrahim, A. S., Spellberg, B., Walsh, T. J., & Kontoyiannis, D. P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-01
- Volume
- 54
- Issue
- suppl_1
- Pages
- S16-S22
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2160371604
- Cited by
- 824
- References
- 58
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.